한글목차

세계 테스토스테론 주사제 시장의 미래는 병원, 재택의료, 전문 클리닉 시장에서 기회가 유망한 것으로 전망됩니다. 세계 테스토스테론 주사제 시장은 2025년부터 2031년까지 CAGR 4.8%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 테스토스테론 치료의 이점에 대한 인식 증가, 의료 시설의 기술 발전, 성선기능저하증 및 관련 질환의 유병률 증가입니다.

• Lucintel은 유형별로는 테스토스테론 에난테이트가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상하고 있습니다.
• 용도별로는 병원이 가장 높은 성장이 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

테스토스테론 주사제 시장의 전략적 성장 기회

테스토스테론 주사제 시장에는 특정 응용 분야에 대한 몇 가지 전략적 성장 기회가 있습니다. 특정 개발 방향에 집중함으로써 대상 그룹의 진단 및 치료 방향과 치료 결과를 개선할 수 있습니다.

• 고령화 인구의 증가 : 꾸준히 증가하는 노인 인구는 테스토스테론 대체 요법에 대한 높은 수요를 창출하고 있으며, 특별히 설계된 제품을 개발하는 플레이어에게 큰 시장 기회를 창출하고 있습니다.
• 인식 제고 캠페인의 증가 : 의료진과 환자들에게 테스토스테론 감소의 징후와 증상에 대해 알리고, 의료진을 옹호하거나 환자를 교육하는 프로그램은 주사 요법에 대한 수요를 창출하고 시장의 범위를 확대할 수 있습니다.
• 병용요법 개발 : 테스토스테론 주사와 다른 호르몬 요법을 결합한 병용요법을 연구함으로써 환자에게 혜택을 주고 성장을 달성할 수 있는 방법을 늘릴 수 있습니다.
• TRT의 원격의료 서비스 : 원격의료 센터를 포함시킴으로써 환자가 원격으로 상담 및 후속 조치를 받을 수 있게 되어 테스토스테론 치료의 이용률이 향상되고, 서비스 제공자에게 더 많은 시장 기회를 창출할 수 있습니다.
• 세계 시장에 대한 관심 : 남성 건강에 대한 인식이 높아지는 신흥 시장으로의 발전은 기업이 미개척 환자 시장에 진입하기 시작하면서 테스토스테론 주사제의 성장에 좋은 기회가 될 것입니다.

기업들은 개인화된 치료에 초점을 맞추고, 접근성을 개선하고, 잠재력 있는 계층을 타겟팅함으로써 이러한 기회를 통해 테스토스테론 주사제 시장이 수년까지 어떻게 진화할 것인지에 대한 혁신을 이루고 있습니다. 이러한 개발에 참여하는 사람들은 아마도 기업 경영과 환자에게 제공되는 치료를 강화할 준비가 되어 있을 것입니다.

테스토스테론 주사제 시장 촉진요인 및 과제

여러 기술적, 경제적, 규제적 요인이 시장 촉진요인 및 극복해야 할 과제로서 테스토스테론 주사제 시장에 영향을 미치고 있습니다. 이러한 역학을 숙지하는 것은 변화하는 시장의 이해관계자들에게 중요합니다.

테스토스테론 주사제 시장을 이끄는 요인은 다음과 같습니다:

1. 저 테스토스테론 증후군의 인식 향상 : 인식과 이해의 향상으로 사람들은 저 테스토스테론 증상을 더 잘 받아들이게 되고, 그 결과 주사 요법에 대한 수요가 증가하고, 환자의 진단율과 치료율이 높아집니다.

2. 제제 기술의 변화 : 테스토스테론 주사제 개발은 제제 기술의 발전과 함께 환자의 순응도를 촉진합니다.

3. 치료비를 지불할 수 있는 환자 증가 : 의료비 상승으로 인해 더 많은 환자가 테스토스테론 대체 요법을 받을 수 있게 되어 이 시장의 성장과 환자의 치료 선택권을 확대할 수 있습니다.

4. 유리한 시장 규제 : 적극적인 규제는 새로운 테스토스테론 제제의 연구 개발, 승인 신청을 촉진하는 경향이 있으며, 제조업체에게 시장을 더욱 개방하는 경향이 있습니다.

5. 남성 건강에 대한 초점 : 테스토스테론 요법을 필요로 하는 이유가 늘어나고 인식이 확산되면 시장은 지금보다 더 커질 것으로 보입니다.

테스토스테론 주사제 시장의 과제는 다음과 같습니다:

1. 호르몬 치료에 대한 낙인 : 때때로 테스토스테론 치료는 낙인(오명)이 따르는 경우가 있습니다. 예를 들어, 부끄러움을 느끼는 등 일부 환자들은 이러한 치료를 받는 것을 주저하는 경우가 있어 시장 성장에 걸림돌이 될 수 있습니다.

2. 새로운 처방 모델 수용 지연 : 테스토스테론 처방 관행과 오남용 가능성에 대한 우려가 높아짐에 따라 더 엄격한 정책이 제정될 수 있으며, 이는 시장 역학에 영향을 미칠 수 있습니다.

3. 높은 치료비 : 테스토스테론 주사제 가격이 높기 때문에 일부 환자는 약을 구입할 수 없어 전체 시장 성장과 환자 순응도에 영향을 미칠 수 있습니다.

이러한 요인은 위의 과제와 함께 상호 연관되어 있으며, 테스토스테론 주사제 시장에 영향을 미칩니다. 기술 혁신을 활용하고 이러한 과제를 극복함으로써 이해관계자들은 환자 결과를 개선하고 테스토스테론 치료 옵션의 추가 발전에 참여할 수 있는 기회를 갖게 됩니다.

목차

제1장 주요 요약

제2장 세계의 테스토스테론 주사제 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2019년부터 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 테스토스테론 주사제 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 테스토스테론 주사제 시장, 유형별
  • 테스토스테론 시피오네이트
  • 테스토스테론 운데카노에이트
  • 테스토스테론 에난테이트
  • 메틸 테스토스테론
  • 기타
• 테스토스테론 주사제 세계 시장, 용도별
  • 병원
  • 홈케어
  • 전문 클리닉
  • 기타

제4장 2019년부터 2031년까지 지역별 시장 동향과 예측 분석

• 지역별 테스토스테론 주사제 세계 시장
• 북미의 테스토스테론 주사제 시장
• 유럽의 테스토스테론 주사제 시장
• 아시아태평양의 테스토스테론 주사제 시장
• 기타 지역의 테스토스테론 주사제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 테스토스테론 주사제 시장 성장 기회, 유형별
  • 세계의 테스토스테론 주사제 시장 성장 기회, 용도별
  • 세계의 테스토스테론 주사제 시장 성장 기회, 지역별
• 세계의 테스토스테론 주사제 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 테스토스테론 주사제 시장 생산능력 확대
  • 세계의 테스토스테론 주사제 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Clarus Therapeutics
• Bayer
• Endo Pharmaceuticals
• Eli Lilly & Company
• Kyowa Kirin
• Viatris
• Novartis
• Pfizer
• J & K Scientific
• Beijing Coupling Technology

영문목차

The future of the global testosterone injectable market looks promising with opportunities in the hospital, home care, and specialty clinic markets. The global testosterone injectable market is expected to grow with a CAGR of 4.8% from 2025 to 2031. The major drivers for this market are the growing awareness about testosterone therapy benefits, technological advancement in healthcare facilities, and the increasing prevalence of hypogonadism and related disorders.

• Lucintel forecasts that, within the type category, testosterone enanthate is expected to witness the highest growth over the forecast period.
• Within the application category, the hospital is expected to witness the highest growth.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain Valuable Insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Testosterone Injectable Market

The testosterone injectable market has several significant trends that change treatment patterns and offer better care to patients. These trends are driven by technological progress, changing characteristics of the population, and the increasing importance of specific health areas.

• Increasing Demand for Male Health: There is a surging interest in men's health, which is increasing the demand for testosterone therapy. This has led to increased diagnoses and an expanded market for injectables.
• Administration Technique Advancements: Recent advancements in injectable formulations, including long-acting esterification, have reduced the number of required injections, hence increasing patient compliance and stable testosterone levels.
• Tailored Treatment for Patients: Individualized hormonal treatments are more effective for patients than their standardized counterparts and lead to better adherence to the regimen.
• Assisted Reproductive Technology: Testosterone therapy is now accessible via telemedicine, which provides the opportunity to continue testosterone therapies while having medications and treatment regimens managed at home, thereby extending the market.
• Regulatory Changes: As the healthcare system becomes more complex, healthcare institutions are becoming more vigilant and undertaking adequate safety monitoring and treatment effectiveness for testosterone prescriptions.

These new trends are redefining the testosterone injectable market by increasing market awareness, enhancing current formulations, and supporting innovative personal treatment solutions. Within this ever-evolving market, these trends will be key in meeting patient requirements and improving the performance of testosterone treatment solutions.

Recent Developments in the Testosterone Injectable Market

The testosterone injectable market has experienced significant developments in recent years, driven by various factors such as rising awareness of testosterone deficiency, advancements in formulation technology, and changing societal attitudes toward hormone replacement therapy. Testosterone is crucial for various bodily functions, including muscle mass regulation, mood stabilization, and overall vitality. Many men, particularly those over the age of 40, experience a natural decline in testosterone levels, prompting an increasing demand for effective therapeutic solutions. In this context, the injectable segment has seen a surge in interest, aided by innovations aimed at improving efficacy, safety, and patient adherence.

• Emergence of Novel Formulations: Recent years have seen the introduction of long-acting testosterone injectables, designed to require less frequent dosing. Products like testosterone undecanoate, which can be administered every 10 to 14 weeks, have gained popularity among patients for providing a more convenient treatment schedule. Innovations in formulation technology, such as microsphere-based delivery systems, have also been developed to enhance pharmacokinetics and minimize fluctuations in hormone levels.
• Regulatory Changes and Approvals: Increased FDA approvals for testosterone replacement therapies (TRTs) have expanded treatment options for patients. With regulatory bodies now more supportive of TRT, several new injectable products have entered the market, reflecting a growing trust in the safety and efficacy of these treatments. This has led to increased competition among manufacturers, which can enhance affordability and accessibility for patients.
• Rising Awareness and Diagnosis: Enhanced public awareness and better diagnostic methodologies for testosterone deficiency have played a crucial role in expanding the patient base for injectable therapies. More healthcare professionals and patients are recognizing the signs of low testosterone, and initiatives aimed at educating both groups are resulting in higher rates of diagnosis and subsequent treatment.
• Market Growth and Investments: The global demand for testosterone injectables has resulted in increased investment and activity within the pharmaceutical industry. Major players are launching new marketing campaigns to promote their products, and several startups are exploring niche opportunities within the market. This overall growth is indicative of a broader trend towards personalized medicine and the desire for tailored therapeutic solutions.
• Technological Advancements: Technological innovations in delivery mechanisms, such as pre-filled syringes and auto-injectors, are improving patient experience and adherence to treatment regimens. These advancements reduce the burden of self-administration and minimize the discomfort typically associated with injections, encouraging more patients to pursue treatment.

Overall, the testosterone injectable market is undergoing a dynamic transformation, marked by innovations in product formulations, regulatory advancements, and increasing acceptance of hormone replacement therapy. The growing awareness surrounding testosterone deficiency and the importance of maintaining hormonal balance among aging populations has further bolstered demand. As the market continues to evolve, stakeholders-including pharmaceutical companies, healthcare providers, and patients-will likely benefit from continued advancements, improved treatment options, and a more personalized approach to testosterone therapy. As we look to the future, it is clear that the interplay of technology, education, and regulatory support will shape the trajectory of the testosterone injectable market for years to come.

Strategic Growth Opportunities for Testosterone Injectable Market

The testosterone injectable market has several strategic growth opportunities within the market for specific application areas. It is possible to improve the diagnostic and therapeutic orientation and treatment results of the target groups by concentrating on particular directions of development.

• Expansion in Aging Population: The steadily growing older population is generating high demand for testosterone replacement therapies, thereby creating a great market opportunity for players to come up with specially designed products.
• Increasing Awareness Campaigns: Programs that advocate for or sensitize health workers and patients to the signs and symptoms of low testosterone can create a need for injectable therapies, thus increasing the scope of the market.
• Development of Combination Therapies: Investigating combination therapies that incorporate testosterone injections with other hormonal therapies can benefit patients and provide more ways in which growth can be achieved.
• Telehealth Services for TRT: The inclusion of telehealth centers will improve the use of testosterone treatments as patients will be able to be consulted and followed up remotely, thus creating more market opportunities for service providers.
• Attention on Global Markets: Entering into developing regions with rising male health awareness presents gratifying chances for growth in testosterone injectables as firms begin to venture into untapped patient markets.

Businesses are innovating on how the market for testosterone injectables will evolve over the years through such identified opportunities by focusing on individualized therapy, improving accessibility, and targeting prospective demographics. Those involved in these developments will likely be poised to enhance the management of businesses and care provided to patients.

Testosterone Injectable Market Driver and Challenges

Several technological, economic, and regulatory factors impact the testosterone injectable market as both drivers of the market and challenges to overcome. Familiarizing oneself with these dynamics is important for stakeholders in the changing market.

The factors responsible for driving the testosterone injectable market include:

1. Increasing Awareness of Low Testosterone Syndrome: Increased awareness and understanding are leading people to accept low testosterone symptoms more, which in turn increases the demand for injectable therapy, thus resulting in higher diagnosis and treatment rates among patients.

2. Changes in Drug Formulation Technologies: Improvements in testosterone injectable forms are courtesy of developments in formulation technologies, hence encouraging patient compliance.

3. Emergence of More Patients Who Can Afford Treatment: Healthcare costs are rising, which means that a higher number of patients can now afford testosterone replacement therapies, leading to growth in this market and a widening of treatment options for patients.

4. Favorable Market Regulations: Positive regulations tend to promote the research, development, and submission of new testosterone formulations for approval, further opening up the market for manufacturers.

5. Focus on Men's Health: As more reasons for testosterone therapy arise and awareness spreads, the market will grow even more than it already is.

Challenges in the testosterone injectable market are:

1. Stigma Related to Hormone Therapy: At times, there can be stigma attached to testosterone therapy, for example, a feeling of embarrassment, which could deter some patients from seeking such treatment and pose a challenge to market growth.

2. Delay in Acceptance of Newer Prescribing Models: Increasing concerns around prescribing habits and possible misuse of testosterone may lead to stricter policies being enacted, which in turn might influence market dynamics.

3. High Treatment Costs: Due to the high prices of testosterone injections, some patients might not afford the medication, therefore affecting the overall growth of the market and patient compliance.

These factors, together with the challenges depicted above, are interrelated and influence the testosterone injectable market. Through the use of technological innovations and overcoming these challenges, stakeholders have the opportunity to improve patient outcomes and participate in the further progress of testosterone treatment options.

List of Testosterone Injectable Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies testosterone injectable companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the testosterone injectable companies profiled in this report include-

• Clarus Therapeutics
• Bayer
• Endo Pharmaceuticals
• Eli Lilly & Company
• Kyowa Kirin
• Viatris
• Novartis
• Pfizer
• J & K Scientific
• Beijing Coupling Technology

Testosterone Injectable by Segment

The study includes a forecast for the global testosterone injectable market by type, application, and region.

Testosterone Injectable Market by Type [Analysis by Value from 2019 to 2031]:

• Testosterone Cypionate
• Testosterone Undecanoate
• Testosterone Enanthate
• Methyl testosterone
• Others

Testosterone Injectable Market by Application [Analysis by Value from 2019 to 2031]:

• Hospitals
• Homecare
• Specialty Clinics
• Others

Testosterone Injectable Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Testosterone Injectable Market

The testosterone injectable market for testosterone replacement therapy is changing over time, and this change is attributed to growing awareness of testosterone replacement therapy (TRT), growth in formulations, and changes in policies. The growth in the quality and quantity of testosterone therapies offered in countries such as the United States, China, Germany, India, and Japan satisfies the increasing number of patients who seek services.

• United States: The problem of low testosterone is being addressed, creating a willing populace to use testosterone injectables despite new formulations on the horizon. Recently, tough rules governing prescriptions have made doctors turn to teaching and monitoring patients.
• China: Testosterone injectables are gaining popularity due to increasing education and acceptance of testosterone therapies in male health. Domestic drug manufacturers are trying to strengthen their product lines to comply with the increasing demand.
• Germany: The growth of the testosterone injection market is being driven by improved development in biotechnology and personalized medicine. The introduction of new formulations by manufacturers has expanded treatment alternatives, and the emphasis on testosterone level monitoring by health professionals is improving.
• India: Awareness of male health issues is increasing, and with it, there is a growing interest in hormone therapy in India. There is a shift towards inexpensive testosterone products as urban populations increase, sustaining the rising demand from pharmaceutical companies.
• Japan: The Japanese market is well-positioning itself thanks to improvements in healthcare technology and a large elderly population. New formulations help patients adhere to their treatment regimens, while government support for research signifies that the country is addressing male health concerns.

Features of the Global Testosterone Injectable Market

Market Size Estimates: Testosterone injectable market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Testosterone injectable market size by type, application, and region in terms of value ($B).

Regional Analysis: Testosterone injectable market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the testosterone injectable market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the testosterone injectable market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the testosterone injectable market by type (testosterone cypionate, testosterone undecanoate, testosterone enanthate, methyl testosterone, and others), application (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Testosterone Injectable Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Testosterone Injectable Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Testosterone Injectable Market by Type
  • 3.3.1: Testosterone Cypionate
  • 3.3.2: Testosterone Undecanoate
  • 3.3.3: Testosterone Enanthate
  • 3.3.4: Methyl testosterone
  • 3.3.5: Others
• 3.4: Global Testosterone Injectable Market by Application
  • 3.4.1: Hospitals
  • 3.4.2: Homecare
  • 3.4.3: Specialty Clinics
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Testosterone Injectable Market by Region
• 4.2: North American Testosterone Injectable Market
  • 4.2.1: North American Market by Type: Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Methyl testosterone, and Others
  • 4.2.2: North American Market by Application: Hospitals, Homecare, Specialty Clinics, and Others
• 4.3: European Testosterone Injectable Market
  • 4.3.1: European Market by Type: Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Methyl testosterone, and Others
  • 4.3.2: European Market by Application: Hospitals, Homecare, Specialty Clinics, and Others
• 4.4: APAC Testosterone Injectable Market
  • 4.4.1: APAC Market by Type: Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Methyl testosterone, and Others
  • 4.4.2: APAC Market by Application: Hospitals, Homecare, Specialty Clinics, and Others
• 4.5: ROW Testosterone Injectable Market
  • 4.5.1: ROW Market by Type: Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Methyl testosterone, and Others
  • 4.5.2: ROW Market by Application: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Testosterone Injectable Market by Type
  • 6.1.2: Growth Opportunities for the Global Testosterone Injectable Market by Application
  • 6.1.3: Growth Opportunities for the Global Testosterone Injectable Market by Region
• 6.2: Emerging Trends in the Global Testosterone Injectable Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Testosterone Injectable Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Testosterone Injectable Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Clarus Therapeutics
• 7.2: Bayer
• 7.3: Endo Pharmaceuticals
• 7.4: Eli Lilly & Company
• 7.5: Kyowa Kirin
• 7.6: Viatris
• 7.7: Novartis
• 7.8: Pfizer
• 7.9: J & K Scientific
• 7.10: Beijing Coupling Technology